Human Plasma-Derived Mannose-Binding Lectin: A Phase I Safety and Pharmacokinetic Study
Open Access
- 16 January 2004
- journal article
- clinical trial
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 59 (1) , 97-102
- https://doi.org/10.1111/j.0300-9475.2004.01357.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Umbilical Cord Mannan‐Binding Lectin and Infections in Early ChildhoodScandinavian Journal of Immunology, 2003
- Low levels of mannose‐binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapyEuropean Journal of Haematology, 2003
- Mannan‐binding lectin and its role in innate immunityTransfusion Medicine, 2002
- Association between deficiency of mannose-binding lectin and severe infections after chemotherapyThe Lancet, 2001
- Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective studyThe Lancet, 2001
- Acute Respiratory Tract Infections and Mannose-Binding Lectin Insufficiency During Early ChildhoodJAMA, 2001
- Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primersJournal of Immunological Methods, 2000
- Reconstitution of Opsonizing Activity by Infusion of Mannan‐Binding Lectin (MBL) to MBL‐Deficient HumansScandinavian Journal of Immunology, 1998
- A second serine protease associated with mannan-binding lectin that activates complementNature, 1997
- Mannose binding protein gene mutations associated with unusual and severe infections in adultsThe Lancet, 1995